↓ Skip to main content

Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress

Overview of attention for article published in Journal of Hematology & Oncology, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
6 X users
patent
2 patents

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
Published in
Journal of Hematology & Oncology, June 2021
DOI 10.1186/s13045-021-01097-z
Pubmed ID
Authors

Yurou Chu, Xiangxiang Zhou, Xin Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 12%
Student > Bachelor 6 9%
Researcher 5 7%
Student > Doctoral Student 3 4%
Student > Postgraduate 3 4%
Other 8 12%
Unknown 34 51%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 18%
Medicine and Dentistry 7 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Chemistry 3 4%
Nursing and Health Professions 2 3%
Other 5 7%
Unknown 35 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2024.
All research outputs
#4,934,302
of 25,754,670 outputs
Outputs from Journal of Hematology & Oncology
#415
of 1,304 outputs
Outputs of similar age
#112,407
of 460,766 outputs
Outputs of similar age from Journal of Hematology & Oncology
#22
of 45 outputs
Altmetric has tracked 25,754,670 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,304 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,766 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.